Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: loading, enzyme-trigger release and cell uptake

J Control Release. 2013 May 10;167(3):276-83. doi: 10.1016/j.jconrel.2013.02.009. Epub 2013 Feb 18.

Abstract

Tamoxifen citrate (TAM), an anticancer drug with amphiphilic properties, was loaded in lecithin/chitosan nanoparticles (LCN) with a view to oral administration. The influence of tamoxifen loading on the physico-chemical properties of nanoparticles was studied. Size, surface charge and morphological properties of tamoxifen-loaded nanoparticles (LCN-TAM) were assessed. The increase in the tamoxifen amount in the LCN-TAM preparation up to 60 mg/100 ml maintained the positive zeta potential value of about +45 mV. A statistically significant decrease in particle size was observed for TAM amounts between 5 and 20mg. A strong influence of loaded tamoxifen on the structure of lecithin/chitosan nanoparticles was observed, supported by the quantification of free chitosan and morphological analysis. A loading of tamoxifen in nanoparticles of around 19% was obtained. The release of the drug from the LCN-TAM colloidal dispersion was measured, showing that tamoxifen citrate was released very slowly in simulated gastro-intestinal fluids without enzymes. When enzymes able to dismantle the nanoparticle structure were added to the dissolution medium, drug release was triggered and continued in a prolonged manner. Tamoxifen-loaded nanoparticles showed cytotoxicity towards MCF-7 cells comparable to that obtained with tamoxifen citrate solution, but the rate of this toxic effect was dependent on drug release. Caco-2 cells, used as a model of the intestinal epithelium, were shown to take up the TAM loaded nanoparticles extensively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Biological Transport
  • Caco-2 Cells
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Drug Delivery Systems*
  • Gastric Juice / chemistry
  • Humans
  • Intestinal Secretions / chemistry
  • Lecithins / chemistry*
  • Lipase / chemistry
  • MCF-7 Cells
  • Muramidase / chemistry
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Nanoparticles / ultrastructure
  • Pancreatin / chemistry
  • Progesterone / chemistry
  • Tamoxifen / administration & dosage*
  • Tamoxifen / chemistry

Substances

  • Antineoplastic Agents
  • Lecithins
  • Tamoxifen
  • Progesterone
  • Pancreatin
  • Chitosan
  • Lipase
  • Muramidase